Related Experiment Video
Updated: Nov 21, 2025

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
A management framework for left sided endocarditis: a narrative review
Francesco Nappi1, Cristiano Spadaccio2,3, Marc R Moon4
1Department of Cardiac Surgery, Centre Cardiologique du Nord de Saint-Denis, Paris, France.
Insights
Left-sided endocarditis (LSE) management is complex, often requiring emergency surgery. Early intervention improves survival, but careful consideration of patient factors and surgical timing is crucial for optimal outcomes in infective endocarditis.
Area of Science:
- Cardiology
- Cardiac Surgery
- Infectious Diseases
Background:
- Left-sided endocarditis (LSE) involves mitral or aortic valves and contiguous structures, representing a significant surgical emergency.
- Management guidelines rely on observational data due to challenges in emergency randomized trials.
- Heart teams guide complex LSE treatment decisions.
Purpose of the Study:
- To propose a decisional algorithm for managing left-sided endocarditis.
- To summarize crucial aspects of LSE management based on current evidence.
- To address the complexities of surgical timing and valve substitute choice in LSE.
Main Methods:
- Review of observational studies and existing literature on LSE management.
- Analysis of factors influencing long-term outcomes in infective endocarditis (IE).
- Development of a clinical decision-making algorithm for LSE.
Main Results:
- Early surgery in complicated IE may improve survival but carries risks of recurrence and dysfunction.
- Key factors for long-term outcomes include preoperative organ failure, prosthetic valve IE, vegetation size, and surgical timing.
- A significant proportion of LSE patients do not undergo surgery, leading to high mortality.
Conclusions:
- LSE management requires individualized decisions considering infection extent, patient status, and surgical history.
- Further validation studies are needed due to the lack of randomized controlled trials.
- A proposed algorithm aids in optimizing LSE treatment strategies.
Abstract:
Left sided endocarditis (LSE) can include the entirety or portion of mitral and/or aortic valve and the structures in their anatomical contiguity and represent a significant portion of emergency surgical activity. Literature and guidelines on the management of LSE relies mainly on observational studies given the difficulty in designing randomized trials in emergency settings. Heart teams (HT) are often called in to difficult decisions on the most appropriate strategy to adopted in case of LSE. Decision-making should take into account the localization and the extension of the infection, patient preoperative status and comorbidities, presence of a previous valve prosthesis and best timing for surgery. Despite evidence suggests that early surgery may improve survival in patients with complicated infective endocarditis (IE), an increased risk of recurrence and postoperative valvular dysfunctions has been reported. The most important factors associated with long-term outcomes are preoperative multiorgan failure, prosthetic mechanical valve IE, vegetation size ≥15 mm, and timing of surgical treatment. Importantly, up to one third of potential candidates do not undergo surgery and these patients experience extremely high mortality rates. Another important point regards the choice of the optimal valve substitute to be used according to the different clinical situation. The lack of RCT in this field and the difficulty to design this type of studies in the case of non-elective conditions further complicates the possibility to achieve a univocal consensus on the best strategy to be adopted in each form of LSE and further validation studies are needed. On the basis of the current evidences a decisional algorithm is proposed summarizing all the crucial aspects in the management of LSE.
More Related Videos
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis
Mitral Stenosis III: Medical Management
Pericarditis III: Medical Management